| David M Weston, MD | |
|
2112 Harrisburg Pike, Ste 202, Lancaster, PA 17601-2644 | |
| (717) 544-3500 | |
| (717) 544-3501 |
| Full Name | David M Weston |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Gastroenterology |
| Location | 2112 Harrisburg Pike, Lancaster, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205831260 | NPI | - | NPPES |
| 006582640002 | Medicaid | PA | |
| 112645389 | Other | PA | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | MD012402E (Pennsylvania) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| David M Weston, MD 2112 Harrisburg Pike, Ste 202, Lancaster, PA 17601-2644 Ph: (717) 544-3500 | David M Weston, MD 2112 Harrisburg Pike, Ste 202, Lancaster, PA 17601-2644 Ph: (717) 544-3500 |
News Archive
A surgeon with the Breast Health Center at Women & Infants Hospital of Rhode Island, a Care New England hospital, is among the first in New England to adopt an innovative new device that improves the treatment of breast cancer by more precisely targeting radiation treatment and providing for better follow-up exams.
Having suggested in 2011 that the urethra is a novel entry site for HIV, a team from the Institut Cochin, has now confirmed this hypothesis and identified the cells and mechanisms brought into play: the immune system cells macrophages, present in the epithelium of the urethra, allow the entry of HIV. This work, published online on the website of the journal Mucosal Immunology, could make it possible to test novel HIV/AIDS prevention strategies.
Alcohol consumption is a common coping response to stress, and historically, it has increased in the United States following catastrophic events, such as terrorist attacks and large-scale natural disasters.
UCB and Immunomedics Inc. announced new lupus drug candidate, epratuzumab, provided a significant reduction in disease activity in patients with moderate to severe active systemic lupus erythematosus (SLE). Data presented at the European League Against Rheumatism (EULAR) meeting in Rome from the phase IIb study, EMBLEM™, showed the clinical efficacy of epratuzumab in patients with SLE.
› Verified 9 days ago
Kaci Elizabeth Christian, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2112 Harrisburg Pike Ste 202, Lancaster, PA 17601 Phone: 717-869-4600 Fax: 717-544-3501 | |
Nancy L Adamopoulos, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 555 N Duke St, Lancaster, PA 17602 Phone: 717-544-8144 | |
Mark H Johnston, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2112 Harrisburg Pike, Suite 202, Lancaster, PA 17601 Phone: 717-544-3500 Fax: 717-544-3501 | |
John B Fileta, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1254 Lititz Pike, Lancaster, PA 17601 Phone: 717-397-4724 | |
Charles R Rost, M.D. Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 2112 Harrisburg Pike, Suite 200, Lancaster, PA 17601 Phone: 717-544-3059 Fax: 717-544-3638 | |
Dr. Paul David Allegretti, D.O. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2112 Harrisburg Pike, Suite 202, Lancaster, PA 17601 Phone: 717-544-3500 Fax: 717-544-3501 | |
Elyse Goveia, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 555 N Duke St, Lancaster, PA 17602 Phone: 717-544-4940 |